Blog

Our Latest Blog Posts
  • Immuntherapie gegen Krebs: Klinische Studie der Phase 1 Interimsanalyse 19
    Mrz

    Immuntherapie gegen Krebs: Klinische Studie der Phase 1 Interimsanalyse

    [vc_row][vc_column width="1/12"][/vc_column][vc_column width="10/12"][laboratory_headings headings_title="Immuntherapie gegen Krebs: Klinische Studie der Phase 1 Interimsanalyse" headings_subtitle="" headings_layout="t-only" laboratory_heading_font_weight="400" laboratory_heading_color="#312783" laboratory_sub_heading_font_weight="400"][vc_separator color="custom" border_width="4" el_width="10" accent_color="#312783"][vc_single_image image="3257" img_size="full" alignment="center" style="vc_box_outline"…

    operator no responses
  • Patentschutz für innovative Technologie-Plattform 09
    Mrz

    Patentschutz für innovative Technologie-Plattform

    [vc_row][vc_column width="1/12"][/vc_column][vc_column width="10/12"][laboratory_headings headings_title="Patentschutz für innovative Technologie-Plattform" headings_subtitle="" headings_layout="t-only" laboratory_heading_font_weight="400" laboratory_heading_color="#312783" laboratory_sub_heading_font_weight="400"][vc_separator color="custom" border_width="4" el_width="10" accent_color="#312783"][vc_single_image image="2672" img_size="full" alignment="center" style="vc_box_outline" border_color="black" css_animation="none"][vc_column_text] BlueSky Immunotherapies hat…

    operator no responses